Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.64 USD | -0.54% | +14.80% | +40.20% |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
May. 20 | Raymond James Upgrades PTC Therapeutics to Market Perform From Underperform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.20% | 2.96B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.14% | 21.97B | |
-5.10% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Insider Sell: Ptc Therapeutics